Skip to main content

Andreas Busch

Equibles does not estimate personal net worth.

About Andreas Busch

Earlier roles on record: Board Member at Absci Corp (ABSI) until September 30, 2022. Absci Corp reported in an 8-K filed March 6, 2026 that Andreas Busch retired as Chief Innovation Officer, effective March 31, 2026. Korsana Biosciences, Inc. reported in an 8-K filed September 30, 2022 that Andreas Busch resigned as Chief Scientific Officer, effective September 30, 2022. The proxy statement of Absci Corp reports total compensation of $1,561,137 for Andreas Busch in fiscal 2025, including a base salary of $712,797. Disclosed compensation is on record for 7 fiscal years.

“On March 3, 2026 (the "Retirement Date"), the Company announced that Andreas Busch, Ph.D., the Company's Chief Innovation Officer, and an employee of the Company's wholly-owned subsidiary Absci GmbH, has informed the Company of his decision to retire, effective March 31, 2026.”
Absci Corp Form 8-K, filed March 6, 2026 · Read the filing
“On and effective September 30, 2022, Andreas Busch, Ph.D. resigned from his position as Chief Scientific Officer of Cyclerion Therapeutics, Inc. (the "Company") to pursue another opportunity.”
Korsana Biosciences, Inc. Form 8-K, filed September 30, 2022 · Read the filing

Affiliation history

Company network

Biotechnology · Healthcare

Board Member

2022-01-01–2022-09-30

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Absci Corp (ABSI) $712,797 $1,561,137
2024 Absci Corp (ABSI) $654,095 $2,644,420
2023 Absci Corp (ABSI) $630,209 $2,151,303
2022 Absci Corp (ABSI) $149,602 $4,732,732
2021 Korsana Biosciences, Inc. (KRSA) $492,320 $782,544
2020 Korsana Biosciences, Inc. (KRSA) $479,667 $806,919
2019 Korsana Biosciences, Inc. (KRSA) $306,205 $3,251,107

Recent activity